Stocks and Investing Stocks and Investing
Thu, May 5, 2016
Wed, May 4, 2016
Tue, May 3, 2016
Mon, May 2, 2016

Joseph Schwartz Downgraded (SRPT) to Sell and Decreased Target to $5 on, May 2nd, 2016


Published on 2024-10-25 12:31:50 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of Leerink Swann, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Sell and Decreased Target from $13 to $5 on, May 2nd, 2016.

Joseph has made no other calls on SRPT in the last 4 months.



There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 2 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yun Zhong of "Janney Montgomery Scott" Initiated at Hold on, Wednesday, April 20th, 2016
  • Brian Abrahams of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $15 on, Tuesday, January 19th, 2016


This is the rating of the analyst that currently disagrees with Joseph


  • Mike Guo of "SunTrust Robinson Humphrey" Downgraded from Hold to Sell and Decreased Target to $4 on, Tuesday, April 26th, 2016

Contributing Sources